SK biotek USA is a global contract development and manufacturing organization (CDMO) known for its expertise in custom chemical development, advanced intermediates, and active pharmaceutical ingredient (API) manufacturing. With state-of-the-art facilities in Korea and Ireland, SK biotek specializes in manufacturing cGMP API and advanced intermediates through advanced synthesis, continuous flow processing, and high containment. They offer a wide range of services from grams to multi-tons across the full product lifecycle for global innovative pharmaceutical companies.
SK biotek's plants in Korea are the leading supplier of late phase and commercial pharmaceutical materials using continuous processing, which offers advantages such as greener, highly efficient, and cost-effective production. Their facility in Dublin has been manufacturing API and intermediates for almost 60 years and has maintained its leadership in the development, scale-up, and commercial manufacture of highly potent chemical intermediates and API. With exceptional technical capabilities and extensive experience in custom development, SK biotek Ireland can offer multi-scale plants capable of handling material with Occupational Exposure Limit (OEL) of 10 ng/m.
Generated from the website